ArticleCancer chemotherapy and pharmacology2014

An evaluation of the potential for drug-drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma.

Mona Darwish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.